Literature DB >> 26104883

Fetal outcome of trisomy 18 diagnosed after 22 weeks of gestation: Experience of 123 cases at a single perinatal center.

Hiromi Nagase1,2, Hiroshi Ishikawa1, Katsuaki Toyoshima3, Yasufumi Itani3, Noritaka Furuya4, Kenji Kurosawa5, Fumiki Hirahara2, Michiko Yamanaka6.   

Abstract

To investigate the pregnancy outcome of the fetuses with trisomy 18, we studied 123 cases of trisomy 18 who were born at our hospital from 1993 to 2009. Among them, 95.9% were diagnosed with trisomy 18 prenatally. Prenatal ultrasound findings showed fetal growth restriction in 77.2%, polyhydramnios in 63.4% and congenital heart defects in 95.1%. For 18 cases, cesarean section (C-section) was chosen, and for 75 cases, transvaginal delivery was chosen. Premature delivery occurred in 35.5%. Stillbirths occurred in 50 cases (40.7%). Fetal demise before onset of labor occurred in 30 cases and fetal demise during labor occurred in 20 cases which was 26.7% of vaginal deliveries. Among the 73 live-born infants, the survival rate for 24 h, 1 week, 1 month and 1 year were 63%, 43%, 33% and 3%. The median survival time was 3.5 days. There was no significant difference between the survival time of C-section and that of vaginal delivery. However, for the births involving breech presentation, the survival time of C-section was significantly longer than that of vaginal delivery. When the fetus is diagnosed with trisomy 18, the parents have to make many choices. These findings constitute critical information in prenatal counseling to the couples whose fetuses have been found to have trisomy 18, especially when they choose palliative approaches in the perinatal management.
© 2015 Japanese Teratology Society.

Entities:  

Keywords:  management; palliative care; prenatal ultrasound findings; prognosis; trisomy 18

Mesh:

Year:  2016        PMID: 26104883     DOI: 10.1111/cga.12118

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  2 in total

Review 1.  Ethical issues about the paradigm shift in the treatment of children with trisomy 18.

Authors:  Agustín Silberberg; Josefina Robetto; Guadalupe Grimaux; Laura Nucifora; José Manuel Moreno Villares
Journal:  Eur J Pediatr       Date:  2019-12-09       Impact factor: 3.183

2.  Outcome after Prenatal Diagnosis of Trisomy 13, 18, and 21 in Fetuses with Congenital Heart Disease.

Authors:  Stephanie Springer; Eva Karner; Christof Worda; Maria Magdalena Grabner; Elisabeth Seidl-Mlczoch; Franco Laccone; Jürgen Neesen; Anke Scharrer; Barbara Ulm
Journal:  Life (Basel)       Date:  2022-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.